Allene Diaz leads AMD Consulting, a new product strategy and portfolio management consulting practice and serves as Senior Advisor to Bain Capital Life Sciences.
Ms. Diaz was Senior Vice President, R&D Portfolio Management at GlaxoSmithKline until June 2020. From 2015-2019, she served as Senior Vice President of Global Commercial Development and Program Strategy and as a member of the Executive Leadership Team at TESARO Inc.
Prior to TESARO, Ms. Diaz held a variety of roles in the EMD Serono and Merck Serono divisions of Merck KGaA, including Senior Vice President, Managed Markets, Senior Vice President, Head of U.S. Oncology Commercial, Vice President, Oncology Marketing and Head of Global Strategic Planning.
Earlier in her career, Ms. Diaz held management, operating, sales, and medical affairs roles at various biopharmaceutical companies, including Pfizer, Parke-Davis, Biogen, and Amylin Pharmaceuticals, among others.
Ms. Diaz currently serves on the boards of directors of Mersana Therapeutics as well as Ionis.
Ms. Diaz served on the boards of directors of Allena Pharmaceuticals from 2019-2022, BCLS Acquisition Corporation from 2020-2022 and Erytech Pharma SA from 2016-2019.